// App-Quantinova.ai

CT168 : Integration of PK data from cancer patients (CP) and healthy volunteer (HV) clinical trials to provide dosing recommendations

Researchers

Presenter

  • Ganesh Moorthy

Principal Investigators

  • Gayle Pageau Pouliot

  • Lorraine Graham

  • Chris Wilks

  • Tinnu Sarvotham

  • Patrick Mitchell

  • Lindsey Jung

  • Yan Li

  • Wenlin Shao

  • Ganesh Mugundu

Medical Centers

  • Clinical and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Waltham, MA

  • Early Oncology, Oncology R&D, AstraZeneca, Waltham, MA

  • Oncology CMC Projects, R&D, AstraZeneca, Macclesfield, United Kingdom

  • Early Oncology, Oncology R&D, AstraZeneca, Waltham, MA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Durvalumab

Outcome

  • N/A

Study Design

  • Open Label

  • Multicenteric

Phase

  • I

Study Id's

  • NCT02740985

  • NCT03710434

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved